Lipid-Lowering Therapy in CKD: Should We Use It and in Which Patients

Publisher： Karger

E-ISSN： 1421-9735|43|1-3|196-199

ISSN： 0253-5068

Source： Blood Purification, Vol.43, Iss.1-3, 2017-01, pp. : 196-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quantitative Analysis of Abdominal Aortic Calcification in CKD Patients Without Dialysis Therapy by Use of the Agatston Score

By  

Kidney and Blood Pressure Research, Vol. 38, Iss. 2-3, 2014-04 ,pp. : 196-204

Karger

Access to resources Recommend Favorite

Influence of Different Lipid-Lowering Strategies on Plaque Volume and Plaque Composition in Patients with Coronary Artery Disease: Role of Intravascular Ultrasound Imaging

By  

Kidney and Blood Pressure Research, Vol. 28, Iss. 5-6, 2006-03 ,pp. : 290-294

Karger

Access to resources Recommend Favorite

HCV Infection during Renal Replacement Therapy:Should We Dialyze All HCV-Positive Patients on Dedicated Machines?

By  

Nephron, Vol. 79, Iss. 4, 1998-07 ,pp. : 479-480

Karger

Access to resources Recommend Favorite

Should We Treat Patients with Incremental Dialysis Prescriptions?

By  

Blood Purification, Vol. 18, Iss. 4, 2000-08 ,pp. : 298-303

Karger

Access to resources Recommend Favorite

Keto Acid Therapy in CKD Patients / Keto Acid Therapy for Patients with Diabetic Nephropathy / Keto Acid Supplementation in Patients Being Treated by Dialysis

By  

American Journal of Nephrology, Vol. 25, Iss. 1, 2005-02 ,pp. : 6-28

Karger

Access to resources Recommend Favorite